Cluster
|
Number of cases
|
IL-5
|
IL-5 positive Ratio %
|
IL-5
|
ECP
|
Total IgE
|
PARC
(CCL18)
|
TARC
(CCL17)
|
Eotaxin
(CCL11)
|
MCP3
(CCL7)
|
MIP1α
(CCL3)
|
ENA-78
(CCL5)
|
MPO
|
IP-10
(CXCL10)
|
IL-22
|
NP %
|
Asthma %
|
N-ERD %
|
1
|
9
|
IL-5
Negative
|
0.0
|
|
|
|
|
|
|
|
|
|
>2
|
|
>3
|
11
|
22
|
0
|
2 |
11 |
IL-5 low |
18.2 |
|
|
|
|
|
|
>3 |
|
|
|
|
|
0 |
9 |
0 |
3 |
8 |
|
25.0 |
|
>2 |
|
|
>2 |
>2 |
>5 |
>5 |
|
|
>5 |
>2 |
13 |
0 |
0 |
4 |
13 |
|
53.8 |
>2 |
>2 |
>2 |
|
>2 |
>2 |
|
|
|
>3 |
|
>5 |
31 |
23 |
0 |
5 |
7 |
IL-5 high |
85.7 |
>3 |
>5 |
>3 |
>5 |
>5 |
>5 |
>5 |
>5 |
|
>5 |
|
|
71 |
43 |
29 |
6
|
16
|
|
100
|
>5
|
>3
|
>5
+SE IgE
|
>3
|
>3
|
>5
|
|
|
|
>2
|
|
|
81
|
19
|
19
|
7
|
2
|
|
100
|
>5
|
>5
|
>5
+SE IgE
|
>5
|
>5
|
>3
|
|
|
|
>5
|
|
|
100
|
50
|
0
|